Showing 481 - 500 results of 659 for search '"pharmacology"', query time: 0.04s Refine Results
  1. 481

    The theses for MD degree by article Editorial

    Published 2011-02-01
    “…Batyukhno - Chronic pancreatitis: disorders of protective immune mechanisms and their pharmacological treatment.S.P. Fedorov – Pharmakokinetics and pharmacodynamics of rabeprazole.…”
    Get full text
    Article
  2. 482

    Viloxazine, a Non-stimulant Norepinephrine Reuptake Inhibitor, for the Treatment of Attention Deficit Hyperactivity Disorder: A 3 Year Update by Hannah W Haddad, Paul B. Hankey, Jimin Ko, Zahaan Eswani, Pravjit Bhatti, Amber N. Edinoff, Adam M. Kaye, Alan D. Kaye

    Published 2022-07-01
    “…Central nervous system (CNS) stimulants are the primary pharmacological therapy used in treatment; however, these stimulant drugs carry a high potential for abuse and severe psychological/physical dependence. …”
    Get full text
    Article
  3. 483

    Fighting Alzheimer’s with Movement: The Role of Physical Activity in Disease Management by Agnieszka Kosińska, Magdalena Balwierz, Karolina Kalinowska, Urszula Świrk, Jan Karczmarz, Joanna Orzechowska, Marika Gutowska, Michał Orzechowski, Aleksandra Paprocka, Paulina Fijałek

    Published 2025-02-01
    “…This highlights the effectiveness of physical activity as a valuable, non-pharmacological approach to managing Alzheimer's. …”
    Get full text
    Article
  4. 484

    PGC-1α activation to enhance macrophage immune function in mycobacterial infections. by Joel R Frandsen, Zhihong Yuan, Brahmchetna Bedi, Zohra Prasla, Seoung-Ryoung Choi, Prabagaran Narayanasamy, Ruxana T Sadikot

    Published 2025-01-01
    “…Importantly, rescuing expression of PGC-1α and TFAM using pharmacologic approaches restored macrophage immune function. …”
    Get full text
    Article
  5. 485

    Linezolid and serotonin syndrome by Haytham A. Wali

    Published 2025-02-01
    “…Assessments of the pharmacological mechanisms, large-scale clinical trials, and cohort studies are essential to elucidate risk factors and outcomes. …”
    Get full text
    Article
  6. 486

    Burning Mouth Syndrome Treated with Mandibular and Maxillary Nerve Blocks by Jamal Hasoon, Christopher Robinson, Ivan Urits, Omar Viswanath, Alan D. Kaye

    Published 2023-03-01
    “…We briefly discuss our experience with a patient who suffered from this conidtion and how it was treated with mandibular and maxillary nerve blocks after failing more conservative pharmacological options.…”
    Get full text
    Article
  7. 487

    Economic Impact of Postoperative Urinary Retention in the US Hospital Setting by Weijia Wang, Arielle Marks-Anglin, Vladimir Turzhitsky, Robert J. Mark, Aurelio Otero Rosales, Nathaniel W. Bailey, Yiling Jiang, Joseph Abueg, Ira S. Hofer, Toby N. Weingarten

    Published 2024-08-01
    “…**Background:** Postoperative urinary retention (POUR) is a common and distressing surgical complication that may be associated with the pharmacological reversal technique of neuromuscular blockade (NMB). …”
    Get full text
    Article
  8. 488

    Modern approaches of effective prevention of NSAIDs-gastropathy by A. Ye. Karateyev

    Published 2015-12-01
    “…This review presents advantages of pantoprazole — a PPI, that possesses the minimal risk of unfavorable pharmacological interaction with drugs of other pharmacological classes.Conclusion. …”
    Get full text
    Article
  9. 489
  10. 490

    Progress on neuromodulation for treatment of central pain by GAN Yu, WAN Jun⁃ge, LI Zhong⁃hua, LI Shuai, HAN Shuai

    Published 2025-01-01
    “…Central pain often arises as a sequela of lesions in the central somatosensory nervous system, and the intensity of pain is generally severe, significantly impacting patients' quality of life. Conventional pharmacological therapies usually have limited efficacy. …”
    Get full text
    Article
  11. 491

    Buprenorphine for Chronic Pain: A Safer Alternative to Traditional Opioids by Suhani Dalal, Ahish Chitneni, Amnon A. Berger, Vwaire Orhurhu, Bilal Dar, Bennett Kramer, Anvinh Nguyen, John Pruit, Charles Halsted, Alan D. Kaye, Jamal Hasoon

    Published 2021-08-01
    “…Buprenorphine offers a safer alternative for patients who require opioids to manage chronic pain, given the unique pharmacological properties that allow it to provide adequate analgesia with less abuse potential.…”
    Get full text
    Article
  12. 492

    The antioxidant potential of bacoside and its derivatives in Alzheimer's disease: The molecular mechanistic paths and therapeutic prospects by Dipanjan Karati, Swarupananda Mukherjee, Souvik Roy

    Published 2025-06-01
    “…Bacoside A, Baccoside B, Apigenin, Betullinic acid, etc. are the pharmacologically active congeners of Brahmi belonging to several chemical families. …”
    Get full text
    Article
  13. 493

    The effectiveness of dance interventions on the cognitive functioning of people with dementia or cognitive impairment: A systematic review by Dauda Salihu, Surajo Kamilu Sulaiman, Umar Muhammad Bello, Osama Mohamed Elsayed Ramadan, Hadiza Yahaya, Muhammad Chutiyami

    Published 2024-11-01
    “…In the search for non-pharmacological interventions, dance has emerged as a potential complementary therapy to support people with dementia or cognitive impairment. …”
    Get full text
    Article
  14. 494

    PHARMACEUTICAL TECHNIQUES FOR THE FABRICATION OF POOR WATERSOLUBLE DRUGS A REVIEW by Rabia Noor

    Published 2024-10-01
    “…Majority of the drugs possesses low solubility leading to poor absorption and erratic bioavailability and thus failed to achieve a desired pharmacological response. Therefore formulation scientists have adopted various techniques to overcome solubility and bioavailability issues following oral administration. …”
    Get full text
    Article
  15. 495
  16. 496

    Progress on neuromodulation for treatment of rare movement disorders by DONG Wen⁃wen, QIU Chang, XU Yi⁃chen, YANG An⁃chao, ZHANG Wen⁃bin

    Published 2025-01-01
    “…Traditional pharmacological treatments for rare movement disorders have limited efficacy. …”
    Get full text
    Article
  17. 497
  18. 498

    Molecular pathogenesis of Cryptosporidium and advancements in therapeutic interventions by Lu Yilong, Zhang Xiaoning, Guan Zhiyu, Ji Rui, Peng Fujun, Zhao Chunzhen, Gao Wei, Gao Feng

    Published 2025-01-01
    “…Ongoing research is focused on understanding the molecular pathogenesis of Cryptosporidium and developing pharmacological treatments. In this review, we examine the signaling pathways activated by Cryptosporidium infection within the host and their role in protecting host epithelial cells. …”
    Get full text
    Article
  19. 499

    Non-alcoholic fatty liver disease: comparative assessment of diagnostic and treatment approaches in the Russian Federation and People’s Republic of China by M. Ch. Semenistaya, Fan Jian-Gao, O. B. Velichenko, Ye. A. Kuznetsova, Ch. S. Pavlov

    Published 2018-08-01
    “…Etiological and pathogenetic features of NAFLD require diverse therapeutic actions from dietic recommendations and physical activity correction of the prescription of various pharmacological agents. Results of clinical efficacy estimation of the new drug Bicyclol in the Russian market, that it was developed in the People’s Republic of China demonstrate reduction of severity of inflammation, steatosis, fibrosis and decrease of NAFLD activity scores.…”
    Get full text
    Article
  20. 500

    Chronic Disease Management in Patients with Non-infectious Arthritis: Challenges and Solutions by WENG Xisheng, ZHANG Fengchun

    Published 2025-01-01
    “…To address these challenges, a systematic strategy for chronic disease management of NIS needs to be developed at the national level, which encompasses increasing popularization of science, improving the referral system, using artificial intelligence (AI) technology to assist in early diagnosis, and implementing interventions including optimized pharmacological/surgical treatments and multidisciplinary collaboration. …”
    Get full text
    Article